logo

Viking Therapeutics, Inc. (VKTX)



Trade VKTX now with
  Date
  Headline
8/10/2018 7:55:42 AM William Blair Is Raising Viking Therapeutics, Inc. (VKTX) FY20 Estimate To -0.79 From -0.89
8/10/2018 7:55:29 AM William Blair Is Increasing Viking Therapeutics, Inc. (VKTX) FY19 Estimate To -0.55 From -0.69
8/10/2018 7:55:17 AM William Blair Is Increasing Viking Therapeutics, Inc. (VKTX) FY18 Estimate To -0.44 From -0.51
8/10/2018 7:54:42 AM William Blair Reiterates Viking Therapeutics, Inc. (VKTX) At Outperform
7/17/2018 7:06:17 AM Viking Therapeutics Announces VK5211 Phase 2 Study Results Selected For Plenary Oral Presentation
6/12/2018 7:05:40 AM Viking Therapeutics Announces Closing Of Public Offering Of 8.625 Mln Shares
6/7/2018 8:33:48 AM Viking Therapeutics Announces Pricing Of $67.5 Mln Public Offering Of Common Stock
6/6/2018 4:03:07 PM Viking Therapeutics Announces Proposed Public Offering Of Common Stock
6/5/2018 7:02:27 AM Viking Therapeutics Completes Enrollment In Phase 2 Study Of VK2809
2/2/2018 8:35:46 AM Viking Therapeutics Prices Public Offering Of 11 Mln Shares At $5/Shr
11/28/2017 7:03:57 AM Viking Therapeutics Says Positive Top-Line Results From Phase 2 Study Of VK5211 For Recovering From Hip Fracture
10/24/2017 7:14:05 AM Viking Therapeutics Presents Results From In Vivo Study Of VK2809 In Biopsy
10/4/2017 7:08:29 AM Viking Says Positive Top-line Results From Proof-of-concept Study Of VK0214 In An In Vivo Model Of X-ALD